Background & Aims: Chronic abdominal symptoms develop in some patients after acute enteric infection. This study examined mechanisms underlying smooth muscle hypercontractility that persists after acute infection in mice. Methods: Euthymic and athymic National Institutes of Health (NIH) Swiss mice were infected with Trichinella spiralis and studied 4 weeks postinfection (PI). Isometric tension was assessed in longitudinal muscle. Cytokine and cyclooxygenase (COX)-2 messenger RNA was determined in the muscularis externa by reverse-transcription polymerase chain reaction. COX-2 protein was identified by immunohistochemistry and prostaglandin E 2 was measured by enzymatic immunoassay. Studies were performed in euthymic and athymic NIH Swiss mice 28 days PI and in the presence or absence of treatment with corticosteroid or COX inhibitors. Results: Muscle hypercontractility was evident in euthymic mice but was attenuated in athymic mice or in steroid-treated euthymic mice 28 days PI. Expression of Th2 cytokines interleukins 4, 5, and 13 was increased during the acute infection but not thereafter. COX-2 was localized to muscle and its enzymatic activity remained significantly increased in the muscle on day 28 PI. Selective COX-2 inhibition in vitro reduced the sustained increase in tension generation. Conclusions: These findings show that COX-2 activation in resident cells of the muscularis externa contributes to the muscle hypercontractility that persists after infection.
Background & Aims: Chronic abdominal symptoms develop in some patients after acute enteric infection. This study examined mechanisms underlying smooth muscle hypercontractility that persists after acute infection in mice. Methods: Euthymic and athymic National Institutes of Health (NIH) Swiss mice were infected with Trichinella spiralis and studied 4 weeks postinfection (PI). Isometric tension was assessed in longitudinal muscle. Cytokine and cyclooxygenase (COX)-2 messenger RNA was determined in the muscularis externa by reverse-transcription polymerase chain reaction. COX-2 protein was identified by immunohistochemistry and prostaglandin E 2 was measured by enzymatic immunoassay. Studies were performed in euthymic and athymic NIH Swiss mice 28 days PI and in the presence or absence of treatment with corticosteroid or COX inhibitors. Results: Muscle hypercontractility was evident in euthymic mice but was attenuated in athymic mice or in steroid-treated euthymic mice 28 days PI. Expression of Th2 cytokines interleukins 4, 5, and 13 was increased during the acute infection but not thereafter. COX-2 was localized to muscle and its enzymatic activity remained significantly increased in the muscle on day 28 PI. Selective COX-2 inhibition in vitro reduced the sustained increase in tension generation. Conclusions: These findings show that COX-2 activation in resident cells of the muscularis externa contributes to the muscle hypercontractility that persists after infection. S tudies in animal models have shown that acute infection of the proximal small intestine and acute inflammation of the colon are associated with altered neuromuscular function in the gut. 1 In NIH Swiss mice infected with the nematode parasite Trichinella spiralis, we have shown hypercontractility of jejunal smooth muscle that persists for 6 weeks after recovery from infection when there is no discernable mucosal inflammation. 2 We have proposed this as a model of postinfective gut dysfunction reminiscent of the clinical entity of postinfective irritable bowel syndrome (PI-IBS). [3] [4] [5] Studies in these patients have shown changes in sensory and motor function in the anorectum as a putative basis for symptom generation. 6, 7 The aim of the present study was to use this model to investigate the inflammatory and immunologic mechanisms underlying the persistent hypercontractility of muscle. We show that T lymphocytes are required for the initiation of the changes in muscle contraction, and that prostaglandin E 2 (PGE 2 ) is required for the maintenance of these changes. The PGE 2 is generated by cyclooxygenase (COX)-2 that is expressed in muscle in this model, illustrating the participation of resident cells in altering function in the postinfected gut. The hypercontractility could be attenuated by administration of corticosteroid or COX inhibitors administered after recovery from infection. These results may have clinical implications because they suggest that gut dysfunction postinfection (PI) may be reversed with anti-inflammatory therapy.
Materials and Methods

Mice and T. spiralis Infection
Athymic and euthymic male NIH Swiss mice (purchased from the National Cancer Institute, Frederick, MD) were kept in sterilized and filter-isolated cages, under controlled ambient temperature and light-dark cycle (14:10 hours). Mice were infected by intragastric inoculation of 300 -400 T. spiralis larvae in 0.1 mL phosphate-buffered saline. The larvae were obtained from infected CD1 mice as previously described. 8 Mice were killed by cervical dislocation at the time points PI indicated in the text. All experimental procedures were in accordance with guidelines drafted by the McMaster University Animal Care Committee and the Canadian Council on the Use of Laboratory Animals.
Experimental Protocols
In a previous study, we found that inflammation in mice was maximal at 10 days PI and had resolved by 14 days, along with expulsion of the parasite from the gut. 9 Thus, we elected to study long-term changes 28 days PI. This timepoint will be also referred to as "previously infected" in the text. Unless otherwise stated, euthymic mice were used throughout the study.
Steroid treatment. Infected mice were allowed to recover from the acute infection up to day 22 PI. On days 23-25 PI, mice received a daily intraperitoneal injection of dexamethasone (0.5 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 ). Control infected mice received intraperitoneal injections of saline. Age-matched noninfected mice received an identical dexamethasone or saline treatment on the same days as the infected mice.
COX-1 and -2 inhibition in vitro. In experiments involving the assessment of muscle function in the presence of COX inhibitors, tissues were prepared as described below and exposed throughout the experiment to the nonselective COX-1/COX-2 inhibitor indomethacin (1 mmol/L) or the selective COX-2 inhibitor celecoxib (10 mg/mL). 10 Indomethacin was dissolved in ethanol, whereas celecoxib was made up in dimethyl sulfoxide (BDH, Toronto, ON) at a concentration of 10 Ϫ2 mol/L and subsequently diluted up to 10,000 times in the working buffer. Control tissues were incubated with the same concentration of ethanol or dimethyl sulfoxide.
Contractility Studies
Tissues were prepared for contractility studies as previously described. 9 In brief, 10-mm segments of proximal jejunum were dissected and hung in the longitudinal axis in warmed (37°C) 20-mL organ baths containing oxygenated (95% O 2 /5% CO 2 ) Krebs solution. One end of the tissue was connected to an isometric force transducer (FT03C; Grass, Quincy, MA), and the other to the armature of the bath. Tissues were allowed to equilibrate in the baths for 45 minutes and then stretched by applying an amount of tension, which in previous studies had been shown to produce a maximum response to carbachol. 9 Responses were recorded on a polygraph (7E; Grass). At the end of each experiment, the mucosa was removed, and the tissues were blotted and weighed for measurement of cross-sectional area using a previously described method. 9 Reverse-Transcription Polymerase Chain Reaction for Th2 Cytokines and COX-2
For analysis of messenger RNA (mRNA) expression of Th2 cytokines, i.e. interleukin (IL)-4, IL-5, IL-13, and COX-2 within the muscle layer, mice were killed, the jejunum was dissected and opened longitudinally on a petri dish, and the mucosa and submucosa scraped off with a coverslip. Successful isolation of muscle was confirmed by a preliminary histologic study. Total RNA was extracted from homogenized muscle using a previously described phenol-chloroform procedure. 11 The concentration of total RNA was determined by measuring absorbance at 260 nm, and its purity was confirmed with the use of the ratio of absorbency at 260 nm to that at 280 nm. RNA was stored at Ϫ70°C until used for reverse-transcription polymerase chain reaction. mRNA was reverse transcribed to yield complementary DNA (cDNA) as previously described. 12 Aliquots (2 mL) of cDNA (0.1 mg) were then mixed with 20 pmol of sense and antisense primers, which were designed based on the available cDNA sequence. IL-4: 13 (sense, 5Ј-GAA TGT ACC AGG AGC CAT ATC-3Ј; antisense, 5Ј-CTC AGT ACT ACG AGT AAT CCA-3Ј); IL-5: 14 (sense, 5Ј-ATG AGA AGG ATG CTT CTG CAC TTG A-3Ј; antisense, 5Ј-GGA ACT CTT GCA GGT AAT CCA GGA-3Ј); IL-13: 15 (sense, 5Ј-TCT TGC TTG CCT TGG TGG TCT CGC-3Ј; antisense, 5Ј-GAT GGC ATT GCA ATT GGA GAT GTT G-3Ј); and COX-2: 16 (sense, 5Ј-TGG TGC CGG GTC TGA TGA TG-3Ј; antisense, 5Ј-GCA ATG CGG TTC TGA TAC TG-3Ј). The positive control used in the polymerase chain reaction reaction was the housekeeping gene glycerol-3-phosphate dehydrogenase (G3PDH), and 20 pmol of each sense primer 17 (5Ј-CCA TGG AGA AGG CTG GGG-3Ј) and antisense primer (5Ј-CAA AGT TGT CAT GGA TGA CC-3Ј) were used to detect it. For reverse-transcription polymerase chain reaction, 5 mg of total RNA aliquot was reverse transcribed in 50 mL volumes containing deoxythymidine triphosphate (200 mmol; Pharmacia, Uppsala, Sweden), Mg 2ϩ (1.5 mmol), and Taq polymerase (2.5 U; GIBCO BRL, Burlington, ON) with corresponding buffer and distilled water. Th2 cytokines or COX-2 were coamplified with G3PDH for 45 cycles with the use of the following parameters: denaturation, 94°C for 30 seconds; annealing, 55°C for 30 seconds; and extension, 72°C for 60 seconds. Polymerase chain reaction products were loaded onto a 2.5% agarose gel and then visualized under UV light after ethidium bromide staining. Comparing the bands of interest with those obtained for G3PDH assessed the amount of specific gene expression.
Measurement of PGE 2 Levels
Muscle layer of jejunum was obtained as described above, snap frozen, and stored at Ϫ70°C until assayed. On thawing, samples were weighed, homogenized, and centrifuged at 4°C. Tissue levels of PGE 2 were assessed using an enzyme-linked immunoassay (BIOTRAK; Amersham Canada, Oakville, ON), according to the manufacturer's directions.
Immunohistochemistry
Full thickness samples of jejunum were rapidly dissected, embedded in ornithine carbamyltransferase compound, and frozen in isopentane and liquid nitrogen. Specimens were cut with a cryostat at 10 -12 mm, placed onto gelatin-coated slides, and processed as previously described. 18 The antibody used to identify the cellular source of COX-2 was a specific rabbit polyclonal directed against the amino acids 570 -598 of the murine sequence of the enzyme molecule (Cayman Chemical, Ann Arbor, MI). Tissue sections were analyzed using a light transmission microscope (DMLS, Leica, Germany). Spec-ificity studies included control experiments commonly applied in immunohistochemical protocols. 18, 19 
Drugs and Solutions
Unless otherwise stated, all the reagents were obtained from Sigma Chemical Co. (St. Louis, MO). The composition of the Krebs solution was as follows (in mmol/L): NaCl, 129.9; KCl, 5.9; CaCl 2 , 1.2; NaCl 2 , 1.2; NaHCO 3 , 15.5; NaH 2 PO 4 , 1.2; and glucose, 11.1 (pH 7.4). The solution was gassed continuously with a mixture of 95% O 2 /5% CO 2 (vol/vol). All drugs were added to the baths in volumes Յ1% of the total bath volume.
Data Expression and Statistical Analysis
Contractile activity was analyzed visually. Responses to carbachol were expressed as milligrams of tension per crosssectional area of tissue, as described in detail elsewhere. 9 All the studies involved at least 4 mice, and results were expressed as the means Ϯ SE of these experiments. Statistical significance was determined at P Ͻ 0.05 using the Student t test for comparisons of 2 means or a one-way analysis of variance for the comparison of more than 2 means, followed by the Bonferroni multiple range analysis.
Results
Effect of Steroid Treatment on Muscle Dysfunction
We first determined whether the persistent hypercontractility of muscle could be suppressed by a brief course of corticosteroid administered on days 23-25 PI. As shown in Figure 1 , steroids had no effect on carbachol-induced muscle contraction in noninfected mice. As expected, muscle hypercontractility was observed on day 28 PI in saline-treated mice. In contrast, muscle hypercontractility was absent in day 28 PI mice that received steroids. These results indicate that the process underlying the persistent hypercontractility of muscle is steroidsensitive and prompt investigation of an inflammatory or immune basis.
Role of T-Lymphocytes in Muscle Dysfunction
To investigate whether the persistent muscle changes were T-cell dependent, we studied T. spiralis infection in euthymic and athymic NIH Swiss mice. As shown in Figure 2 , after the infection, both euthymic and athymic mice exhibited a significant increase in carbachol-induced contraction, which was time-dependent. The maximum increase in contractility was evident at days 8 -10 PI in both euthymic and athymic mice. However, only euthymic mice exhibited hypercontractility evident on days 21 and 28 PI; in athymic mice, muscle contractility at these time points was not significantly different from control. These results indicate that T cells play an important role in the development of sustained muscle hypercontractility PI.
Th2 Cytokine mRNA Expression in Muscle
Because T. spiralis infection is associated with a Th-2 immune response, we examined whether increased tension development PI was accompanied by increased gene expression for Th-2 cytokines in the muscle layer. As shown in Figure 3 , during the acute infection (i.e., day 10 PI), mRNA expression for IL-4, IL-5, and IL-13 Figure 1 . Tension generated by muscle in response to carbachol (1 mmol/L) in noninfected control mice and in mice 28 days after T. spiralis infection. Mice were treated for 3 days after recovery from the infection with either dexamethasone 0.5 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 (s) or saline (ᮀ). Age-matched noninfected controls followed the same treatment protocol. Values represent the means Ϯ SE from each group (n ϭ 6). **Significant difference from noninfected mice treated with saline (P Ͻ 0.01). *Significant difference from previously infected mice treated with saline (P Ͻ 0.01). was significantly increased over noninfected controls. However, this increased expression was transient and was not evident at day 28 PI. Taken in conjunction with the data from athymic mice, these results are consistent with the notion that T cells are important for the initiation of muscle hypercontractility, likely via Th2 cytokine secretion, but do not play a role in the maintenance of this response. This prompted an evaluation of other mediators in the muscle layer.
COX-2 mRNA Expression in Muscle
We assessed mRNA expression of the inducible isoform COX-2 in the muscularis externa. As shown in Figure 4 , COX-2 expression was minimal in noninfected mice but increased significantly by Ͼ50-fold during the acute phase of the infection. Moreover, COX-2 expression remained significantly increased ϳ30-fold over controls on day 28 PI.
COX-2 Immunolabeling in Muscle
Immunohistochemistry was performed to localize the COX-2 protein in the muscle layer. As shown in Figure 5 , weak COX-2 immunoreactivity was detectable in the longitudinal muscle layer of the jejunum in noninfected mice. The positive labeling was localized to the cytoplasm and cell surface of smooth muscle cells ( Figure  5A ). In previously infected mice, the intensity of the COX-2 staining was markedly and consistently increased in smooth muscle cells of both longitudinal and circular layers ( Figure 5B ). The specificity of the staining was confirmed by immunoblocking experiments ( Figure 5C ).
PGE 2 Concentration in Muscle
To assess COX-2 enzymatic activity, we next evaluated PGE 2 concentration in the muscle layer, and the results are shown in Table 1 . The concentration of PGE 2 was more than 100% greater in mice at day 28 PI compared with noninfected controls. Steroid treatment significantly reduced the increase in PGE 2 on day 28 PI. 
Role of COX-2 in Muscle Hypercontractility
We next examined whether COX-2 contributed to the hypercontractility of muscle. As shown in Figure  6 , indomethacin did not significantly alter carbacholinduced muscle contraction in noninfected mice. In contrast, increased tension generation by muscle from day 28 PI mice was significantly reduced in the presence of indomethacin. Similarly, the selective COX-2 inhibitor celecoxib had no significant effect on tension generation by muscle from noninfected mice, but it significantly reduced tension generation in muscle from mice at day 28 PI.
Discussion
In the present study, we explored mechanisms underlying changes in the contractility of intestinal muscle that persist after resolution of a transient nematode infection in mice. Increased contractility reaches its maximum during the infection but remains significantly increased above control values 28 days PI. This raised the possibility that the changes seen at days 21 and 28 simply reflect a slow time course of recovery of the hypercontractile state of muscle induced during the infection. Alternatively, the hypercontractile state of muscle could reflect an active process maintained by the local production of mediators. The distinction between these explanations is important because only the latter scenario lends itself to manipulation and reversal. Our results clearly support the notion that the infection-induced persistent hypercontractility of muscle in this model reflects an active process that can be reversed by a brief administration of corticosteroids PI.
Our results identify a critical role for T cells in the induction of the hypercontractile state. This is reflected by the attenuation of the hypercontractile response in athymic mice both during and after infection. The T-cell dependence of contractile changes seen during the acute infection is in agreement with previous findings in the mouse 20 and rat. 21 In the mouse, our study also identified a T cell-independent component of the hypercontractility observed during the acute infection, and this is consistent with the present study in which a degree of NOTE. Mice were infected with T. spiralis and allowed to recover for 28 days PI. PGE 2 was assayed in jejunal muscle by enzyme immunoassay. In experiments designed to test the effect of steroids on muscle PGE 2 levels, animals were treated with dexamethasone (0.5 mg ⅐ kg Ϫ1 ⅐ day Ϫ1 ) between days 23 and 25 PI. Values represent means Ϯ SE obtained in each group; n represents the number of animals. a Statistically significant from noninfected mice (P Ͻ 0.05). b Statistically significant from previously infected, saline-treated animals (P Ͻ 0.05).
hypercontractility was still evident in infected athymic NIH Swiss mice. The increased expression of Th-2 cytokines in the muscularis externa is in keeping with observations made in mucosal tissue and mesenteric lymph nodes from T. spiralis-infected mice. [22] [23] [24] Recently, we have shown that the hypercontractility is critically dependent on the STAT-6 (signal transduction and activation of transcrition) pathway by which the Th-2 cytokines IL-4 and IL-13 exert their actions. 25 Furthermore, we have also shown that IL-4 and IL-13 interact with murine smooth muscle cells to increase the contractile response to carbachol via STAT-6. 26 IL-4 may also enhance contractility of murine intestinal muscle via cholinergic nerves and via the release of leukotriene D4. 27 We have also shown that IL-5 contributes, to a lesser degree, to the hypercontractile state during this infection. 28 We postulate that Th-2 cells that infiltrate the muscularis externa during acute infection are responsible for initiating the hypercontractility of muscle but do not contribute to the maintenance of this response after recovery from the infection. This is based on the observation that the T-cell infiltrate in the muscularis externa is transient and has regressed by the end of the enteric phase of this infection. 29 In addition, the Th-2 cytokines, which we consider important in the generation of muscle hypercontractility, are expressed in the muscularis externa only during the enteric phase of infection.
The increased expression of the inducible COX-2 isoform after inflammation is well recognized. 30 Prostaglandins are known to exert powerful effects on intestinal smooth muscle, 31 and increased PGE 2 production in the muscularis externa has been shown in a rabbit model of colitis. 32 During T. spiralis infection, prostaglandin release has been correlated with rapid expulsion of the parasite during the enteric phase of the infection, most likely through activation of intestinal secretion and peristalsis. 33 Clinically, prostaglandins have been implicated in chronic diarrhea 34 and in some forms of IBS. 35 Our data support a role for COX-2-derived PGE 2 as the mediator of the postinfective hypercontractile state of muscle in this model. COX-2 mRNA expression in muscle increased several-fold during the acute phase of the infection. However, more importantly, COX-2 mRNA, as well as protein immunolabeling, remained significantly up-regulated after infection. These changes were accompanied by increased COX-2 enzymatic activity as reflected by increased PGE 2 levels in muscle. COX-2 immunoreactivity was identified in the muscle layer and within smooth muscle cells. Previous studies in other systems have shown the induction of COX-2 in smooth muscle cells by cytokines 36, 37 as well as the ability of this enzyme to modulate the contractile response of muscle during inflammation. 38 We are aware of only 1 study showing increased prostaglandin production in the muscularis externa during gastrointestinal inflammation, but that study did not extend its observations to the postinflammatory state. 32 The ability of indomethacin or celecoxib to attenuate the hypercontractile state PI clearly implicates prostaglandins as mediators of this condition. Although T cells are critical for the induction of the hypercontractile state, the precise relationship between Th-2 cytokines and the expression of COX-2 in our model is unclear. In bone marrow-derived cells, IL-4 generally inhibits COX-2 expression and this is in keeping with the anti-inflammatory properties of IL-4. 39 -41 This may not, however, apply to non-bone marrow-derived cells where there is Values represent the means Ϯ SE from each group (n ϭ 6). **Significant difference from muscle from noninfected mice and not exposed to the inhibitors (P Ͻ 0.01). *Significant difference from muscle from previously infected mice and not exposed to the inhibitors (P Ͻ 0.01).
evidence of IL-4 -induced COX-2 expression. 42 Alternatively, it is possible that other cytokines are expressed in the muscularis externa in response to IL-4 and induce local COX-2 expression. A candidate mediator in this regard is transforming growth factor ␤, which is known to induce COX-2 and PGE 2 production in human airway smooth muscle 43 and, in preliminary studies, is expressed in the muscularis externa of this model (Akiho, Barbara, and Collins, unpublished observation, April 2001).
We propose this model as one of PI-IBS. Although IBS is a clinical descriptor diagnosed on the basis of symptom profiles, it is also defined as a "functional disorder" in which changes in sensory as well as motor function occur in the absence of a discernible structural abnormality, particularly within the mucosal compartment. We feel our model captures some components of the latter definition, in that we have identified neural and muscle abnormalities in the absence of demonstrable structural change. 2 The changes occur after recovery from the enteric phase of an infection and therefore are reminiscent of PI-IBS. Although some T. spiralis larvae encyst and remain in skeletal muscle, studies in rats and other mouse strains indicate that this is not accompanied by persistent changes in enteric muscle function 8, 9 and do not, therefore, contribute to the model.
The results of this study have implications for our understanding and treatment of IBS. It has been estimated from a retrospective study that approximately one third of IBS patients have an acute onset of their symptoms suggestive of an acute infection. 44 A large cohort study found that acute gastroenteritis was a strong risk factor for the development of IBS, with a relative risk of 11.9. 45 Thus, PI-IBS is likely to be a significant component of the IBS population with its attendant socioeconomic impact. 46 Not all patients recovering from acute gastroenteritis develop IBS. [3] [4] [5] Genetic factors 47 in addition to behavioral factors 4,7 may influence the expression of IBS after infection, and it is instructive to point out that this animal model is species and strain dependent; no persistent hypercontractility of muscle was seen in Sprague-Dawley rats 21 or in B10BR mice 9 after T. spiralis infection. This suggests that genetic factors are important, although the locus of genetic susceptibility remains to be identified. Attention is drawn to a recent report suggesting that some IBS patients are genetically susceptible to inflammation 47 ; such patients may not down-regulate inflammatory responses efficiently.
This model indicates that mediators produced by resident cells, such as smooth muscle, actively maintain the persistent changes in gut physiology in the postinfective state. Moreover, our results indicate that the functional changes in the tissue may be reversed using nonselective (corticosteroid) or selective (COX inhibitor) anti-inflammatory agents administered after recovery from the infection. This provides a basis for considering trials of anti-inflammatory drugs in patients with PI-IBS.
